Conmed Corp
CNMD53.275USD
+0.985+1.88%
Market hours （ET）Quotes delayed by 15 min
1.65BMarket Cap
13.88P/E TTM
More Details of Conmed Corp Company
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Company Info
Ticker SymbolCNMD
Company nameConmed Corp
IPO dateJul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
Number of employees3900
Security typeOrdinary Share
Fiscal year-endJul 23
Address11311 Concept Boulevard
CityLARGO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code33773
Phone17272142974
Websitehttps://www.conmed.com/
Ticker SymbolCNMD
IPO dateJul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
General Surgery
182.97M
56.95%
Orthopedic Surgery
138.29M
43.05%
By RegionUSD
Name
Revenue
Proportion
United States
183.76M
57.20%
Europe & Middle East & Africa
63.68M
19.82%
Asia Pacific
43.71M
13.61%
Americas (excluding the United States)
30.11M
9.37%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
General Surgery
182.97M
56.95%
Orthopedic Surgery
138.29M
43.05%
Shareholding Stats
Updated: Wed, May 14
Updated: Wed, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.74%
The Vanguard Group, Inc.
11.30%
EARNEST Partners, LLC
9.04%
Capital Research Global Investors
5.41%
State Street Global Advisors (US)
4.20%
Other
55.31%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.74%
The Vanguard Group, Inc.
11.30%
EARNEST Partners, LLC
9.04%
Capital Research Global Investors
5.41%
State Street Global Advisors (US)
4.20%
Other
55.31%
Shareholder Types
Shareholders
Proportion
Investment Advisor
64.48%
Investment Advisor/Hedge Fund
42.65%
Hedge Fund
3.72%
Research Firm
3.28%
Pension Fund
1.86%
Bank and Trust
0.79%
Individual Investor
0.58%
Family Office
0.05%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
649
36.35M
117.48%
-4.52M
2025Q1
664
36.95M
119.42%
-4.31M
2024Q4
649
36.65M
118.59%
-2.95M
2024Q3
644
35.57M
115.39%
-3.57M
2024Q2
660
37.07M
120.35%
-1.36M
2024Q1
657
36.04M
117.06%
-2.92M
2023Q4
642
36.87M
119.89%
-1.61M
2023Q3
624
36.40M
118.42%
-2.31M
2023Q2
606
36.19M
118.37%
-3.41M
2023Q1
592
37.15M
121.58%
-2.82M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.56M
14.74%
-49.31K
-1.07%
Mar 31, 2025
The Vanguard Group, Inc.
3.50M
11.31%
-68.84K
-1.93%
Mar 31, 2025
EARNEST Partners, LLC
2.80M
9.05%
-10.48K
-0.37%
Mar 31, 2025
Capital Research Global Investors
1.67M
5.41%
+96.23K
+6.10%
Mar 31, 2025
State Street Global Advisors (US)
1.30M
4.21%
-56.92K
-4.19%
Mar 31, 2025
Managed Account Advisors LLC
1.28M
4.14%
+139.05K
+12.19%
Mar 31, 2025
Westwood Management Corp. (Texas)
1.24M
4%
+360.34K
+41.07%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.17M
3.79%
+311.29K
+36.08%
Mar 31, 2025
Champlain Investment Partners, LLC
1.04M
3.37%
-258.19K
-19.85%
Mar 31, 2025
Silvercrest Asset Management Group LLC
1.04M
3.35%
+34.88K
+3.49%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.67%
Invesco S&P SmallCap Health Care ETF
1.15%
ROBO Global Healthcare Technology & Innovation ETF
1.15%
Harbor Human Capital Factor US Small Cap ETF
1.06%
WisdomTree US SmallCap Quality Dividend Growth
0.31%
Royce Quant Small-Cap Quality Value ETF
0.28%
SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.25%
Franklin US Small Cap Multifactor Index ETF
0.24%
Principal U.S. Small-Cap ETF
0.23%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.67%
Invesco S&P SmallCap Health Care ETF
Proportion1.15%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.15%
Harbor Human Capital Factor US Small Cap ETF
Proportion1.06%
WisdomTree US SmallCap Quality Dividend Growth
Proportion0.31%
Royce Quant Small-Cap Quality Value ETF
Proportion0.28%
SPDR S&P 600 Small Cap Value ETF
Proportion0.25%
iShares S&P Small-Cap 600 Value ETF
Proportion0.25%
Franklin US Small Cap Multifactor Index ETF
Proportion0.24%
Principal U.S. Small-Cap ETF
Proportion0.23%
Dividend
A total of
119.19M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
Feb 27, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 05, 2023
Mar 14, 2023
Dec 05, 2022
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 05, 2023
Dec 15, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
